JPRN-UMIN000023657已完成未知
Study of the efficacy of sucroferric oxyhydroxide (chewable tablet) on the control of CKD-MBD and improvement of renal anemia in hemodialysis patients with hyperphosphatemia. - Study of the efficacy of sucroferric oxyhydroxide (chewable tablet) on the control of CKD-MBD and improvement of renal anemia in hemodialysis patients with hyperphosphatemia.
Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group0 个研究点目标入组 50 人开始时间: 2016年8月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with a serum ferritin level of 300 ng/mL or more at the latest examination prior to entry 2)Patients with a history of hypersensitivity to the ingredients of sucroferric oxyhydroxide (chewable tablet) 3)Patients who are or may be pregnant or are breast-feeding 4)Patients who are considered inappropriate for participation in this study by the investigator's judgment
研究者
相似试验
已完成
不适用
Efficacy and safety of sucroferric oxyhydroxide on hemodialysis patientsChronic kidney diseaseJPRN-UMIN000032867Department of Nephrology, hypertension and Endocrinology, Nihon University School of Medicine60
已完成
不适用
The effect of sucroferric oxyhydroxide starting from a small amountChronic renal failureJPRN-UMIN000034640Saitama Tsukinomori Clinic40
招募中
不适用
Oral administration of sucroferric oxyhydroxide during hemodialysis sessions against resistant hyperphosphatemiaResistant hyperphosphatemia in maintenance hemodialysis patientsJPRN-UMIN000031337Dialysis Center, JA Toride Medical Center20
已完成
不适用
Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis PatientsHemodialysis patients with iron-deficiency anemiaJPRN-UMIN000004814kobe university school of medicine, division of nephrology and kidney center30
进行中（未招募）
1 期
A Study to Investigate the Effect of ß-Hydroxy-ß-Methylbutyrate (HMB) on Skeletal Muscle Wasting in Early Critical Illness.Critical illnessMedDRA version: 20.0Level: PTClassification code 10077264Term: Critical illnessSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2016-003557-15-GBGuy's and St Thomas NHS Foundation Trust68